文献速递甲状腺疾病

单次高强度聚焦超声治疗大型良性甲状腺结节

Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
PubMed 文献 · Thyroid · 2017-03-22

本研究评估超声引导下高强度聚焦超声(HIFU)消融大型良性甲状腺结节在6个月时的疗效。73个结节按消融前体积分组,>30 mL组6个月体积缩小48.1%,显著低于<10 mL组的77.6%和10-30 mL组的67.9%;消融前结节体积>30 mL和每结节体积总能量较低是消融成功率低的显著因素。

要点

  • >30 mL结节6个月体积缩小48.1%,显著低于<10 mL组的77.6%和10-30 mL组的67.9%。
  • 消融前结节体积>30 mL(OR=7.813)和每结节体积总能量较低(OR=3.313)是消融成功率低的显著因素。
  • 对于大型结节,作者认为初始治疗后3至6个月追加HIFU治疗可能优于同一次治疗中序贯治疗。

核心结论

  • 单次HIFU消融对良性甲状腺结节6个月时的体积缩小高度有效,但>30 mL结节的缩小程度明显低于较小结节。
  • 消融前结节体积和每结节体积总能量均是消融成功率的显著决定因素。
  • 对于大型结节,作者认为初始治疗后3至6个月追加HIFU治疗可能优于同一次治疗中序贯治疗。

研究设计与样本

  • 经伦理批准后,分析所有连续接受症状性良性甲状腺结节HIFU消融且随访≥6个月的患者。
  • 共73个结节被成功治疗并随访≥6个月。
  • 结节按消融前体积分组:I组<10 mL,II组10-30 mL,III组>30 mL。
  • 治疗后第1周、1个月、3个月和6个月用超声测量结节体积。
  • 主要结局为6个月后结节体积变化,消融成功定义为体积缩小>50%。

主要发现

  • 总体6个月中位体积缩小68.3%(范围22.77-96.50%)。
  • 6个月时,III组体积缩小48.1%,显著低于I组的77.6%(p<0.001)和II组的67.9%(p=0.002)。
  • 6个月时III组消融成功比例显著低于其他两组(p<0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-intensity focused ultrasound (HIFU) is a new promising thermal ablation technique for treating benign thyroid nodules, but its effectiveness in larger-sized nodules has been less well described. The present study aimed to evaluate the treatment efficacy (i.e., extent of shrinkage at six months) of large-sized benign thyroid nodules by ultrasound (USG)-guided HIFU ablation. MATERIALS AND METHODS: After ethics approval, all consecutive patients who underwent HIFU ablation of a symptomatic benign thyroid nodule with six or more months of follow-up were analyzed. Treated nodules were categorized according to their pre-ablation volume (group I: <10 mL; groups II: 10-30 mL; group III: >30 mL). After treatment, the nodule volume was measured by USG at one week, one month, three months, and six months. Total energy delivered to each nodule (in kJ) and the time taken (in minutes) for that delivery were automatically recorded. The primary outcome was a change in nodule volume after six months, where percentage nodule volume change was calculated as (baseline volume - volume at six months)/(baseline volume) × 100. Ablation success was defined as >50% volume reduction. RESULTS: Seventy-three nodules were treated successfully and followed for ≥6 months. The overall median six-month volume reduction was 68.3% (range 22.77-96.50%). At six months, group III had a significantly less volume shrinkage than group I (48.1% vs. 77.6%; p < 0.001) and group II (48.1% vs. 67.9%; p = 0.002). Also, the proportion of ablation success at six months in group III was significantly less than in the other two groups (p < 0.001). Pre-ablation nodule volume >30 mL (odds ratio = 7.813 [confidence interval 1.908-32.258]; p = 0.004) and lower total energy per nodule volume (odds ratio = 3.313 [confidence interval 1.113-9.688]; p = 0.029) were significant factors for less ablation success. CONCLUSIONS: Single-session HIFU ablation was highly effective in causing shrinkage of benign thyroid nodules at six months, but the extent of shrinkage for larger-sized nodules (>30 mL) was noticeably less than that of smaller-sized nodules. Both pre-ablation nodule volume and total energy per nodule volume were significant determinants of ablation success. For larger-sized nodules, additional HIFU treatment three to six months after initial treatment might be preferred over sequential treatment within the same session.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lang BH, Woo YC, Chiu KW, et al. Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules. Thyroid. 2017. PMID: 28326895. doi:10.1089/thy.2016.0664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。